Bert Coleman

Dr. Bert Coleman

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2022 in Future Foods
Verified
Journal Article
Open access
BCBert Coleman
Bert Coleman
CPChristof Van Poucke
Christof Van Poucke
BDBavo Dewitte
Bavo Dewitte
ARAnn Ruttens
Ann Ruttens
TMTanja Moerdijk-Poortvliet
Tanja Moerdijk-Poortvliet
JRJohan Robbens
Johan Robbens

23 July 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BCBert Coleman
Bert Coleman
EVElke Vereecke
Elke Vereecke
KLKatrijn Van Laere
Katrijn Van Laere
LNLucie Novoveska
Lucie Novoveska
JRJohan Robbens
Johan Robbens
Carotenoids, with their diverse biological activities and potential pharmaceutical applications, have garnered significant attention as essential nutraceuticals. Microalgae, as natural producers of these bioactive compounds, offer a promising avenue for sustainable and cost-effective carotenoid production. Despite the ability to cultivate microalgae for its high-value carotenoids with health benefits, only astaxanthin and β-carotene are produced on a commercial scale by Haematococcus pluvialis and Dunaliella salina, respectively. This review explores recent advancements in genetic engineering and cultivation strategies to enhance the production of lutein by microalgae. Techniques such as random mutagenesis, genetic engineering, including CRISPR technology and multi-omics approaches, are discussed in detail for their impact on improving lutein production. Innovative cultivation strategies are compared, highlighting their advantages and challenges. The paper concludes by identifying future research directions, challenges, and proposing strategies for the continued advancement of cost-effective and genetically engineered microalgal carotenoids for pharmaceutical applications.